Accelerate Diagnostics, Inc. (AXDX)

0,9056 +0,0105 (+1,17%) A partir del 09:39AM EDT. Mercado abierto.

Accelerate Diagnostics, Inc.

3950 South Country Club Road
Suite 470 4th Floor
Tucson, AZ 85714
United States
520 365 3100
https://acceleratediagnostics.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 134

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Jack Phillips	CEO, President & Director	595k	N/A	1966
Mr. David Patience	Chief Financial Officer	285,27k	N/A	1986
Mr. Lawrence Michael Mertz	Chief Technology Officer	335,94k	N/A	1963
Ms. Maya Gowri	Senior VP & Head of Operations	N/A	N/A	N/A
Laura Pierson	Investor Relations Officer	N/A	N/A	N/A
Mr. John Meduri	Chief Strategy Officer	N/A	N/A	N/A
Mr. Chris Thode	Senior Vice President of US Commercial	N/A	N/A	N/A
Ms. Rita Boukamel	Senior VP & Head of EMEA	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Gobierno corporativo

El ISS Governance QualityScore de Accelerate Diagnostics, Inc., a día 1 de mayo de 2024, es 5. Las puntuaciones base son Auditoría: 10; Tablero: 3; Derechos de los accionistas: 2; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.